U.S. Professional Services Stock News

What Trump Media & Technology Group’s recent trading performance signals for investors With no single headline event driving attention, Trump Media & Technology Group (DJT) has been drawing interest mainly because of its trading performance, including a 1 day gain of 2.95% and a month decline of 18.58%. See our latest analysis for Trump Media & Technology Group. That recent 1 day 2.95% share price gain sits against a weaker backdrop, with the 30 day share price return of 18.58% and year to...

JPMorgan Chase (NYSE:JPM) has launched the American Dream Initiative, a multi year nationwide program for U.S. small businesses. The bank plans nearly US$80b in new small business lending over 10 years. The effort includes hiring about 1,000 new small business bankers and providing expanded advisory and mentorship services. The initiative also targets community investment and policy advocacy tied to small business growth and economic opportunity. For you as an investor, this move highlights...

Pratt & Whitney, an RTX subsidiary, received a multi billion dollar contract modification for F135 engines tied to the global F 35 Joint Strike Fighter program. The newly definitized, multi year award covers F135 propulsion systems and related support for international customers. RTX is increasing production speed and capacity to meet demand associated with this long duration program. For NYSE:RTX, this contract sits on top of an already sizeable defense footprint and a current share price...

Wondering if Builders FirstSource at around US$78.85 is starting to look attractive again, or if the market is still pricing in too much optimism. The stock is down around 6.9% over the past week, 24.4% over the past month, and 24.6% year to date, with a 36.9% decline over the last year and a 65.7% gain over five years. Recent headlines have focused on Builders FirstSource within broader discussions about U.S. construction activity, housing demand, and building products suppliers. This helps...

Steel Dynamics (NasdaqGS:STLD) announced that long serving directors Richard P. Teets, Jr. and Gabriel L. Shaheen plan to retire from its board at the upcoming annual meeting. The changes will reduce long term board presence and open seats for new directors once shareholders vote at the meeting. Both directors have served during key phases of the company’s development in the steel and metals recycling sector. For you as an investor, this matters because board composition shapes how Steel...

Elastic Cloud Hosted has received FedRAMP High authorization on AWS GovCloud (US), allowing use by U.S. federal agencies for highly sensitive workloads. This approval places Elastic directly into one of the most security focused cloud segments within the government and defense market. The development extends Elastic's existing government presence at a time when the NYSE:ESTC share price stands at $49.41. For investors tracking NYSE:ESTC, the FedRAMP High authorization ties a clear...

ZTO Express (Cayman) (ZTO) stock has drawn attention after recent trading left it with a one-day return near 1% and a past three months total return around 15%, prompting fresh interest in its valuation. See our latest analysis for ZTO Express (Cayman). That 1-day share price return of 1.04% comes after a 90-day share price return of 15.16%. The 1-year total shareholder return of 26.79% contrasts with weak 3 and 5 year total shareholder returns, which hints at improving but still debated...

In the wake of its recent earnings announcement, Texas Roadhouse attracted fresh attention as several analysts adopted a more positive stance despite management reiterating that beef-driven commodity inflation will weigh on profit margins through the year. The shift suggests that analysts are focusing on the resilience of Texas Roadhouse’s underlying business model even as cost pressures remain firmly in view. Next, we’ll explore how this renewed analyst optimism amid persistent beef...

Corcept Therapeutics (CORT) has received U.S. Food and Drug Administration approval for Lifyorli, to be used with nab paclitaxel in adults with platinum resistant ovarian, fallopian tube, or primary peritoneal cancer. See our latest analysis for Corcept Therapeutics. Corcept’s latest FDA approval lands after a volatile stretch, with a 12.71% 7 day share price return and a 6.78% 30 day share price return, alongside a 1 year total shareholder return of 58.53% decline. Meanwhile, 3 and 5 year...

What Mastercard’s recent share performance signals for investors Mastercard (MA) has drawn attention after recent share performance, with the stock showing a 2.0% gain over the past day but declines over the week, month, past 3 months and past year. See our latest analysis for Mastercard. The recent 1 day share price gain contrasts with weaker 1 month and year to date share price returns. At the same time, 3 and 5 year total shareholder returns in the high 30% range point to a longer term...

New independent cost impact model evaluates Indivior's extended-release buprenorphine (SUBLOCADE) in U.S. correctional facilities. The model suggests SUBLOCADE, a monthly injectable for opioid use disorder, may meaningfully cut staff time and related costs versus other treatments. Findings, published in a peer reviewed journal, highlight potential operational benefits and treatment access gains for jails and prisons. For investors watching Indivior Pharmaceuticals (NasdaqGS:INDV), this...

EQT Corporation recently completed an upsized cash tender offer for multiple series of senior notes maturing between 2027 and 2031, raising its aggregate purchase cap to US$1.40 billion and adjusting sub-caps across key 2029 issues. This move signals active balance sheet management as EQT retires higher-cost debt, potentially reshaping its interest expense profile and financial flexibility. We’ll now examine how EQT’s expanded US$1.40 billion debt tender offer affects the company’s...

Wondering whether CubeSmart's current share price still offers value, or if most of the opportunity has already been priced in? This article breaks down what the numbers actually say about the stock. CUBE has had a mixed run recently, with a 3.4% decline over 7 days, a 12.7% decline over 30 days, a 1.4% gain year to date, and an 11.4% decline over the last year, which can change how the market views its risk and return profile. Recent coverage has focused on CubeSmart's share price moves and...

DTE Energy (DTE) drew fresh attention after its recent trading session, with the stock closing at $146.06 and short term returns showing mixed moves over the past week, month and past 3 months. See our latest analysis for DTE Energy. Looking beyond the latest move, DTE Energy’s share price return of 12.0% year to date and 12.5% over 90 days points to building momentum. The 1 year total shareholder return of 9.2% and 3 year total shareholder return of 48.6% reflect a solid longer term outcome...

Starwood Property Trust (STWD) has been drawing attention after recent share price moves, with the stock closing at $17.37. Investors are weighing this against its income profile and diversified real estate financing model. See our latest analysis for Starwood Property Trust. The recent 1-day share price return of 1.94% comes after weaker short term moves, with 30 day and year to date share price returns of 2.47% and 5.70% declines. However, the 3 year total shareholder return of 32.79%...

Enerpac Tool Group Corp. recently reported its second quarter fiscal 2026 results, showing higher sales of US$154.81 million but lower net income of US$16.31 million year over year, updated its full‑year 2026 guidance, and completed a US$65.9 million share repurchase program initiated in October 2025. Management also highlighted an active pipeline of potential acquisitions, backed by low leverage of 0.6x and an untapped revolver, signaling that disciplined M&A remains a central element of...

Home Depot (NYSE:HD) has appointed Dr. Franziska "Fran" Bell as executive vice president and chief technology officer. Dr. Bell will lead enterprise-wide technology, digital product management, and AI efforts for the company. She brings experience from senior technology and AI roles at Ford, BP, and Uber. Home Depot, a major home improvement retailer serving DIY customers and professionals, is moving further toward tech-driven retail operations with this leadership change. Retailers...

If you are wondering whether Seagate Technology Holdings is still offering value after a strong run, the starting point is to understand how the current share price lines up against a few different valuation checks. The stock last closed at US$362.43, with returns of 26.0% year to date and 332.1% over 1 year, but also short term pullbacks of 10.3% over 7 days and 11.1% over 30 days that may have shifted how the market is thinking about risk and reward. Recent attention on Seagate has been...

StepStone Group (STEP) is back on investor screens after recent share price swings, with the stock up over the past month but lower across the past 3 months and year to date. See our latest analysis for StepStone Group. The recent rebound, including a 7.81% 1 month share price return from a last close of US$46.51, comes after a much weaker 90 day share price return of a 27.99% decline. The 3 year total shareholder return of 114.48% contrasts with a 1 year total shareholder return of an 8.57%...

If you are wondering whether Pegasystems is offering fair value at its recent price, it helps to break the story into what the share price has done, what has been in the headlines, and how that stacks up against a structured valuation checkup. The stock last closed at US$41.48, with returns of a 6.5% decline over 7 days and a 5.1% decline over 30 days, while still showing a 19.6% gain over 1 year and 73.4% over 3 years, and a 26.0% decline year to date and a 29.0% decline over 5...

Abbott Laboratories is integrating its Precision Oncology portfolio into Flatiron Health's OncoEMR platform used by a wide U.S. oncology network. The move brings Abbott's advanced cancer diagnostics directly into clinicians' electronic workflows, aiming to simplify ordering and results review. This development follows Abbott's expansion into cancer diagnostics through its deal with Exact Sciences. For investors tracking NYSE:ABT, this news sits against a mixed share price picture. The stock...

Wondering if DRDGOLD at around US$27.65 still offers value, or if most of the easy gains are already behind it? This article walks through what the current price might imply. The stock has returned 1.7% over the last 7 days, while the 30 day return sits at a 28.9% decline, against an 8.8% decline year to date and an 81.5% return over the past year, with a very large 3 year and 226.1% 5 year return. Recent coverage has focused on DRDGOLD as part of broader gold and precious metals...

Recent performance snapshot for D.R. Horton D.R. Horton (DHI) has seen its share price move lower recently, with a 1 day return of a 1.2% decline, a 7 day return of a 4.5% decline, and a 1 month return of a 17.4% decline. Over longer periods, the stock shows a past 3 month return of an 8.9% decline, a year-to-date return of a 9.1% decline, and a 1 year total return of 5.5%, alongside a 3 year total return of 39.1% and a 5 year total return of 50.4%. See our latest analysis for D.R...

If you are wondering whether Elevance Health's current share price reflects its true worth, this article will walk you through what the numbers actually say. Recently, the stock has retreated, with returns of a 1.5% decline over 7 days, an 11.0% decline over 30 days, a 19.6% decline year to date, and a 33.1% decline over the past year from a last close of US$284.79. These moves have arrived alongside ongoing sector attention on large managed care names and investor focus on how insurers are...